title: Rapid tracer lactate influx into canine skeletal muscle.
abstract: This study evaluated the effects of various lactate transport inhibitors and competitors on rapid tracer lactate influx into the canine gastrocnemius-plantaris muscle (GP). GPs of 25 anesthetized dogs were perfused with red blood cell-free media in situ. At 0.9 mM lactate concentration ([La]), GP oxygen uptake (2.6 +/- 0.1 ml.kg-1.min-1) and net lactate output (-0.039 +/- 0.007 mmol.kg-1.min-1) were similar to values during blood perfusion. Rapid tracer lactate influx was inferred by a paired-tracer dilution method at nominal perfusate [La] values of 1, 5, 10, 25, and 50 mM. The maximal tracer influx rate (Umax) decreased significantly with each increase in unlabeled [La]. A saturation effect was suggested by the fact that percent inhibition of Umax began to reach a plateau at the higher unlabeled [La] values. The inhibition of Umax was 20.5 +/- 2.9% at 5 mM, 34.1 +/- 3.3% at 10 mM, 47.3 +/- 2.7% at 25 mM, and 56.1 +/- 2.8% at 50 mM [La]. Umax was also inhibited by various inhibitors/competitors of lactate transport as follows (% inhibition): 50 mM alpha-cyano-4-hydroxy-cinnamate (69.2 +/- 4.9%), 1.5 mM phloretin (25.4 +/- 5.5%), 0.1 mM 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (0.3 +/- 1.9%), 0.5 mM p-chloromercuribenzenesulfonic acid (72.9%), 0.5 mM furosemide (+ 2.8%), 25 mM pyruvate (52.4 +/- 2.9%), and 50 mM DL-lactate (50.2 +/- 4.0%). These experiments support the notion that lactate influx into canine skeletal muscle is a function of both a linear (possible diffusive) component and a Michaelis-Menten (carrier-mediated) component.
authors.affiliation: Department of Health and Human Performance, Auburn University, Alabama 36849.
authors.forename: L B
authors.initials: LB
authors.lastname: Gladden
authors.forename: R E
authors.initials: RE
authors.lastname: Crawford
authors.forename: M J
authors.initials: MJ
authors.lastname: Webster
authors.forename: P W
authors.initials: PW
authors.lastname: Watt
mesh_terms: D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001784:Blood Gas Analysis; D004285:Dogs; D005260:Female; D066298:In Vitro Techniques; D007700:Kinetics; D007773:Lactates / Q000378:metabolism*; D019344:Lactic Acid; D008297:Male; D008353:Mannitol / Q000378:metabolism; D009119:Muscle Contraction / Q000502:physiology; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects / Q000502:physiology; D010477:Perfusion; D005082:Physical Exertion / Q000502:physiology*
chemical_list: D000963:Antimetabolites; D007773:Lactates; D019344:Lactic Acid; D008353:Mannitol; D010100:Oxygen